Details
Title
Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy
Author
Schnekenburger, Michael 1 ; Lorant, Anne 1 ; Gajulapalli, Sruthi Reddy 2 ; Rajora, Ridhika 2 ; Lee, Jin‐Young 2 ; Mazumder, Aloran 2 ; Yang, Haeun 2 ; Christov, Christo 3 ; Kang, Hyoung Jin 4 ; Pirotte, Bernard 5 ; Diederich, Marc 2
1 Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg, Luxembourg
2 Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea
3 Faculté de Médecine, Université de Lorraine, Vandœuvre‐lès‐Nancy, France
4 Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Republic of Korea
5 Laboratory of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium
1 Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Luxembourg, Luxembourg
2 Research Institute of Pharmaceutical Sciences & Natural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea
3 Faculté de Médecine, Université de Lorraine, Vandœuvre‐lès‐Nancy, France
4 Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Republic of Korea
5 Laboratory of Medicinal Chemistry, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium
Pages
915-920
Section
LETTER TO THE JOURNAL
Publication year
2024
Publication date
Aug 1, 2024
e-ISSN
2523-3548
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3095082591
Copyright
© 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.